MedTrace Logo

A Study of Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer

NCT03902600 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2026-01-28

No results posted yet for this study

Summary

This study will observe side effects for patients who receive a 3-week course of radiation and chemotherapy for pancreas cancer. Blood samples will be collected before and after treatment to assess pancreas cancer DNA levels and its impact on outcomes.

Conditions

Interventions

RADIATION

Moderately Hypofractionated RT

Patients will be treated with moderately hypofractionated radiation treatment

Sponsors & Collaborators

Principal Investigators

  • Kenneth W. Merrell, MD · Mayo Clinic in Rochester

  • Krishan R. Jethwa, MD · Mayo Clinic in Rochester

  • Terence T. Sio, MD, MS · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-10
Primary Completion
2021-11-11
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03902600 on ClinicalTrials.gov